Genetically augmented tissue engineering of the musculoskeletal system.

Recent advances in gene transfer technology permit the design of strategies to improve the outcome of orthopaedic tissue engineering by genetic means. Using ex vivo and in vivo strategies, genes have been transferred successfully to, and expressed within, numerous tissues of the musculoskeletal system, including articular cartilage, meniscus, intervertebral disc, bone, tendon, ligament, synovium, and muscle. With these technologies, various genes encoding modulatory species of ribonucleic acid or proteins such as growth factors, receptors, and transcription factors could be used in the context of genetically augmented tissue engineering. Proof of principle has been established in numerous animal models, and a human protocol for the transfer of genes to synovium already is underway. Progress so far permits cautious optimism of a successful outcome to these pursuits.

[1]  Simon C Watkins,et al.  Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. , 1996, Human gene therapy.

[2]  H. Blau,et al.  Muscle-mediated gene therapy. , 1995, The New England journal of medicine.

[3]  James D. Kang,et al.  Adenovirus‐Mediated Gene Transfer to Nucleus Pulposus Cells: Implications for the Treatment of Intervertebral Disc Degeneration , 1998, Spine.

[4]  Y. Kaneda,et al.  Transient introduction of a foreign gene into healing rat patellar ligament. , 1996, The Journal of clinical investigation.

[5]  P. Robbins,et al.  Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. , 1997, Osteoarthritis and cartilage.

[6]  Y. Kaneda,et al.  In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes. , 1997, Arthritis and rheumatism.

[7]  P. Robbins,et al.  A 1998 status report on orthopedic gene therapy , 1998 .

[8]  S W O'Driscoll,et al.  The Repair of Major Osteochondral Defects in Joint Surfaces by Neochondrogenesis with Autogenous Osteoperiosteal Grafts Stimulated by Continuous Passive Motion: An Experimental Investigation in the Rabbit , 1986, Clinical orthopaedics and related research.

[9]  H. Blau,et al.  Recent advances in inducible gene expression systems. , 1998, Current opinion in biotechnology.

[10]  F. Graham,et al.  Intramarrow cytokine gene transfer by adenoviral vectors in dogs. , 1997, Human gene therapy.

[11]  J. Bonadio,et al.  Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. , 1995, The Journal of clinical investigation.

[12]  S. Abramson,et al.  Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo. , 1997, Osteoarthritis and cartilage.

[13]  G. Finerman,et al.  Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[14]  D. Grande,et al.  Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondral repair , 1998, Gene Therapy.

[15]  T Ochi,et al.  Early biological effect of in vivo gene transfer of platelet-derived growth factor (PDGF)-B into healing patellar ligament , 1998, Gene Therapy.

[16]  M Oyama,et al.  Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging , 1999, Gene Therapy.

[17]  S. Woo,et al.  Early expression of marker genes in the rabbit medial collateral and anterior cruciate ligaments: The use of different viral vectors and the effects of injury , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[18]  Steven C. Ghivizzani,et al.  Viral vectors for gene therapy. , 1998, Pharmacology & therapeutics.

[19]  M. Wasko,et al.  Gene therapy for rheumatic diseases. , 1998, Arthritis and rheumatism.

[20]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[21]  K. Takeshita,et al.  Adenovirus vector-mediated gene transduction to chondrocytes: in vitro evaluation of therapeutic efficacy of transforming growth factor-beta 1 and heat shock protein 70 gene transduction. , 1997, The Journal of rheumatology.

[22]  M. Aoki,et al.  Adenovirus‐mediated gene transfer into tendon and tendon sheath , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[23]  K. Marshall,et al.  Resurfacing of articular cartilage explants with genetically-modified human chondrocytes in vitro. , 1998, Osteoarthritis and cartilage.

[24]  P. Robbins,et al.  Gene transfer to the rabbit patellar tendon: potential for genetic enhancement of tendon and ligament healing. , 1996, Gene therapy.

[25]  J. Allay,et al.  LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. , 1997, Human gene therapy.

[26]  P. Wehling,et al.  Transfer of Genes to Chondrocytic Cells of the Lumbar Spine: Proposal for a Treatment Strategy of Spinal Disorders by Local Gene Therapy , 1997, Spine.

[27]  P. Robbins,et al.  Potential role for gene therapy in the enhancement of fracture healing. , 1998, Clinical orthopaedics and related research.

[28]  Freddie H. Fu,et al.  Myoblast‐mediated gene transfer to the joint , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[29]  J. Leiden,et al.  Systemic delivery of recombinant proteins by genetically modified myoblasts. , 1991, Science.